CRMD Other | CORMEDIX INC.

CORMEDIX INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-03-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 Par Value · CRMD · Nasdaq Global Market.
2026-03-05: Form 10-K; Item Smaller reporting company; As filed Yes.
2025-11-12: Form 10-Q; Item Stock registered under Section 12(b); As filed Common stock, $0.001 par value · CRMD · NASDAQ.
2025-11-12: Form 10-Q; Item Smaller reporting company; As filed Yes.

Filed	Form	Item	As filed
2026-03-05	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · CRMD · Nasdaq Global Market
2026-03-05	10-K	Smaller reporting company	Yes
2025-11-12	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2025-11-12	10-Q	Smaller reporting company	Yes
2025-08-07	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2025-08-07	10-Q	Smaller reporting company	Yes
2025-05-06	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2025-05-06	10-Q	Smaller reporting company	Yes
2025-03-25	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · CRMD · NASDAQ
2025-03-25	10-K	Smaller reporting company	Yes
2025-03-25	10-K	Well-known seasoned issuer	No
2024-10-30	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2024-10-30	10-Q	Smaller reporting company	Yes
2024-08-14	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2024-08-14	10-Q	Smaller reporting company	Yes
2024-05-09	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2024-05-09	10-Q	Smaller reporting company	Yes
2024-03-12	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · CRMD · NASDAQ
2024-03-12	10-K	Smaller reporting company	Yes
2024-03-12	10-K	Well-known seasoned issuer	No
2023-11-14	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2023-11-14	10-Q	Smaller reporting company	Yes
2023-08-08	10-Q	Smaller reporting company	Yes
2023-05-15	10-Q	Smaller reporting company	Yes
2023-03-30	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · CRMD · NASDAQ
2023-03-30	10-K	Smaller reporting company	Yes
2023-03-30	10-K	Well-known seasoned issuer	No
2022-11-10	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2022-11-10	10-Q	Smaller reporting company	Yes
2022-08-11	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2022-08-11	10-Q	Smaller reporting company	Yes
2022-05-12	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · Nasdaq Global Market
2022-05-12	10-Q	Smaller reporting company	Yes
2022-03-29	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · CRMD · Nasdaq Global Market
2022-03-29	10-K	Smaller reporting company	Yes
2022-03-29	10-K	Well-known seasoned issuer	No
2021-11-09	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2021-11-09	10-Q	Smaller reporting company	Yes
2021-08-12	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2021-08-12	10-Q	Smaller reporting company	Yes
2021-05-13	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NASDAQ
2021-05-13	10-Q	Smaller reporting company	Yes
2021-03-30	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · CRMD · Nasdaq Global Market
2021-03-30	10-K	Smaller reporting company	Yes
2021-03-30	10-K	Well-known seasoned issuer	No
2020-11-05	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NYSE
2020-11-05	10-Q	Smaller reporting company	Yes
2020-08-10	10-Q	Stock registered under Section 12(b)	Common stock, $0.001 par value · CRMD · NYSEAMER
2020-08-10	10-Q	Smaller reporting company	Yes
2020-05-11	10-Q	Smaller reporting company	Yes
2020-03-16	10-K	Smaller reporting company	Yes
2020-03-16	10-K	Well-known seasoned issuer	No
2019-11-14	10-Q	Smaller reporting company	Yes
2019-08-14	10-Q	Smaller reporting company	Yes
2019-05-29	10-K/A	Smaller reporting company	Yes
2019-05-29	10-K/A	Well-known seasoned issuer	No
2019-05-13	10-Q	Smaller reporting company	Yes
2018-11-14	10-Q	Smaller reporting company	Yes
2018-08-14	10-Q	Well-known seasoned issuer	No
2018-05-15	10-Q	Well-known seasoned issuer	No
2018-03-19	10-K	Well-known seasoned issuer	No
2017-11-09	10-Q	Well-known seasoned issuer	No
2017-08-09	10-Q	Well-known seasoned issuer	No
2017-05-10	10-Q	Well-known seasoned issuer	No
2017-03-16	10-K	Well-known seasoned issuer	No
2016-11-09	10-Q	Well-known seasoned issuer	No
2016-08-04	10-Q	Well-known seasoned issuer	No
2016-05-10	10-Q	Well-known seasoned issuer	No
2016-03-15	10-K	Well-known seasoned issuer	No
2015-11-12	10-Q	Well-known seasoned issuer	No
2015-08-06	10-Q	Well-known seasoned issuer	No
2015-05-07	10-Q	Well-known seasoned issuer	No
2015-03-12	10-K	Well-known seasoned issuer	No
2014-11-13	10-Q	Well-known seasoned issuer	No
2014-08-14	10-Q	Well-known seasoned issuer	No
2014-05-15	10-Q	Well-known seasoned issuer	No
2014-03-31	10-K	Well-known seasoned issuer	No
2014-03-04	10-Q/A	Well-known seasoned issuer	No
2014-03-04	10-Q/A	Well-known seasoned issuer	No
2014-03-04	10-K/A	Well-known seasoned issuer	No
2013-11-19	10-Q	Well-known seasoned issuer	No
2013-11-19	10-Q/A	Well-known seasoned issuer	No
2013-08-14	10-Q	Well-known seasoned issuer	No
2013-03-27	10-K	Well-known seasoned issuer	No
2012-04-26	10-K/A	Well-known seasoned issuer	No
2012-03-19	10-K	Well-known seasoned issuer	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Neurogene Inc. (NGNE)		$0.625B	-4.46
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61